| | |
| | ![]()  | | Friday, May 29, 2020 |  | | Dear Startup Investor,
Neil here.
Yesterday, I got in touch with you about something that's been top of mind for most of us lately: a vaccine for the novel coronavirus.
It's the only thing that'll allow us to return to our normal lives and set the global economy back on track. Not only could it save billions of human lives... It could also save economy trillions of dollars that stand to be lost if strict quarantine measures remain in place.
One of my most crucial angel investing philosophies is to back companies that solve big problems in big markets... And it doesn't get any bigger than this. The upside potential for whatever company figures out a viable vaccine first is virtually unlimited.
Which is exactly why dozens of companies have already joined the race. Do a quick Google search for "vaccine startups" and you'll find countless stories about tiny companies working towards the same goal. They're all over the world, too - I personally know of companies in Italy, India, Massachusetts, and England that are all exploring different approaches to the problem. And those are just the ones I'm familiar with.
COVID-19 has created a unique opportunity for companies worldwide to leverage different types of tech - from biotech to AI and beyond - for the same general purpose. It's almost like watching a contest play out: Using the tools you have on your table, build a solution to the problem at hand.
It's truly inspiring to watch... And someday, when we're able to look back at this experience from a safe distance, I think we'll remember how the entrepreneurial spirit brought the whole world together to achieve a common goal.
But there's something else we'll remember, too: The incredible growth and financial success of the winning company and its backers.
There are a few confounding factors that make it tougher than ever to identify a frontrunner. Not only is the playing field extremely crowded... but the circumstances surrounding this research essentially boil down to total unbridled chaos.
Conditions like these are exactly why I'm always touting the importance of having a network. Let's face it - medtech is not my forte. I'm more of a software/marketing guy. But I do know a Silicon Valley veteran (legend is more like it) who specializes in this field.
His name is Michael Robinson - you've met him once or twice before. He's my go-to guy for all things tech. If there's a cutting-edge breakthrough happening somewhere out there, Michael's probably known about it for a few months already. So I wasn't that surprised to learn that he's already called a laundry list of CEOs, biochemists, and vaccinologists - and gotten to the bottom of what they had to say.
He's got his eye on one tiny company that looks like the best possible candidate for this race. They've got proprietary tech... a stellar track record... and a star CEO to boot. And they could be shipping out their first million doses by the end of this year.
Just click here to learn more about this company - and how you could have a chance to make 3,000% gains from the race for a vaccine.
I'll be back soon.
Until next time,
Neil |
| | Trending | | You Could See 3,000% Returns on this COVID-19 Solution | | A coronavirus vaccine is the only thing that could return us to a sense of normalcy. It could set the global economy back on track. It could save billions of human lives and trillions of dollars. And one tiny company is looking like the definite frontrunner in the race for a cure. | |
|
|
| | Special Situation: How to Make Seven Figures on Five Stocks | | For the first time ever, Tom Gentile is sharing how you could potentially turn five stocks into over $1 million (depending on your investment) - and get paid extraordinary amounts of money before these stocks even begin to move. Best part? You could see this extra cash materialize within the next 24 hours. | |
|
| | One Industry Now Looks Stronger than Ever | | Demand for cannabis products has skyrocketed since quarantine began, and it's signaling a move in the right direction for the industry as a whole. I fully expect the cannabis industry to keep growing, too. But cannabis can do a whole lot more than just get people high and alleviate pain... it has the potential to cure some of humanity's most debilitating ailments. And I've got my eye on a startup that's doing some lifechanging work in this space. | |
|
|
| | Stay Connected | | The best way to receive the most timely, actionable opportunities from Money Morning is by joining our text messaging service, Red Alert - free of charge.
| |
|
| | By texting INCOME to 50525, I agree to receive autodialed and prerecorded marketing messages and calls from Money Map Press, LLC and Money Morning's Red Alert text message service, and partners at the phone number you provide, even if my number is on a national, state or corporate do not call list, and agree to the Privacy Policy and Terms of Use (including class action waiver and arbitration provision). Consent is not a condition of purchase. Msg vary per user (up to 30 msgs/month or more, depending on user's actions) Msg&data rates may apply. | Please do not reply to this email. It was sent from an unmonitored mailbox.
You are receiving this e-mail at phanphuongthanh89.822152@blogger.com, as part of your subscription to The Startup Investor. To remove your email from this list: unsubscribe here.
To cancel, or for any other questions or requests, please contact our Customer Service team:
Online
Phone: 866-310-1498 (North America) 410-501-5876 (International)
Mail: The Startup Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201
Our Customer Service team is available Monday ‑ Friday between 9:00 AM and 5:00 PM ET.
© 2020 Angels & Entrepreneurs. All Rights Reserved.
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.
We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Angels & Entrepreneurs. 1125 N Charles Street, Baltimore, MD 21201.
Website | Privacy Policy | Terms & Conditionshttp://link.e.angelsandentrepreneurs.com/wf/unsubscribe?upn=SVR9z3LgXEwEIVbUkFIuhfIKPV96lSE9UseWeXZ52MI4WY4eEn-2FXQBTN4MGeOz0GseIyndgO8daCHIwjmPi0EySCaAsypuV8RNEMBC-2FVlkhIHWMm1hw0uSXu4GkwGu9TAayNV8TQjBBSMH1t8f3YsH-2BEq2eiGipWZqe-2B8-2FM83BW0PLWRHvzNABv2mbfX6aOk7ySFSxqvM4G7p-2BnrjSSvPiH0BopsJ0IJ2AL5NgbfOnqPI3Hin07BFbTRNIuG8jbp-2FX25s-2FN4h6n6vYcu9oGF2qENaoUoCRtY6-2BgfO-2FE08ks12gPx50WsQamBBZ-2BQeVPRcar0LhOTOX6cjSoIqKQnDV887sTj-2F0jPu8wH4-2B8KnbO1CKk5Wq9SeZppvzrEnF0EcgOt1H4cFh5EOPpAWqYE1yk7dhmgV410-2FWF-2BWOTjYgnAnr3jREumpScACG-2BC4ysHgYKR7YpB9DCgfK0OMAeM3rzNLGLY6hDrbfJs5E7IGdC8dWqBIqrJR3qlJuseH1N1SBgVKAuLIewT8EieMN-2FsR2d519rioVYs7tfgNm9rUoBPuZlkXP8ttJPV2xLHhXzG3kB2HJ0CxvzoXxEGfz4xfpDd2WREqXeijBiD8H-2F5htyrIVc-2FmKvd8P3iB1mgehorCnkcHgTvmNeDCTrh84GWxI9KUZjDO4RQwlYofVRcnDjvOPmcT30o-2FMsaAUFxF9aMlpmKhaV13-2FMJxbDfmvXqIVUXEHkKVHjAdPUSr-2FFp2hqKEW8i0G4oa6Ld2as7VNyThUBoKgpW-2Fz0yPqAzGHWE3WSdhenieRW0oT4Q2mTNFCcGTN65r7s0wSNQwLYJcoDjM7l9svWIzmDzZtpA9I1lyd4r-2ByE6LAnqiDUHqfJRQ5oSNHREpBEBvBxfup-2FY41Mt3kzD3BmT7YylvdBW-2BAgd88PYjM46LKoyJkFFxLWucAGVivyHmySUD88-2Fevxaek6r7m-2FTyGzwT1JElBL2pYfb2Q-3D-3D |
|
No comments:
Post a Comment